• Real Time Chart Real Time Chart
  • Stock Profile Stock Profile
  • Financials As Reported

    • accession Number 0001682852-23-000021
    • accounts Payable Current 389,000,000
    • accounts Receivable Net Current 1,113,000,000
    • accumulated Other Comprehensive Income Loss Net Of Tax --267,000,000
    • allocated Share Based Compensation Expense 75,000,000
    • amendment Flag false
    • assets 24,125,000,000
    • assets Current 12,122,000,000
    • available For Sale Securities Debt Maturities Single Maturity Date 1970-05-30
    • cash And Cash Equivalents At Carrying Value 3,441,000,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3,461,000,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 244,000,000
    • cik 1,682,852
    • city Area Code 617
    • common Stock Par Or Stated Value Per Share 0.0001
    • common Stock Shares Authorized 1,600,000,000
    • common Stock Shares Issued 384,000,000
    • common Stock Shares Outstanding 384,000,000
    • comprehensive Income Net Of Tax 182,000,000
    • contract With Customer Liability 1,892,000,000
    • contract With Customer Liability Current 1,219,000,000
    • cost Of Goods And Services Sold 792,000,000
    • current Fiscal Year End Date --12-31
    • date Filed 2023-05-04
    • depreciation Depletion And Amortization 78,000,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic 0.2
    • earnings Per Share Diluted 0.19
    • effective Income Tax Rate Continuing Operations 1.259
    • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized 789,000,000
    • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 P3Y2M12D
    • entity Address Address Line 1 200 Technology Square
    • entity Address City Or Town Cambridge,
    • entity Address Postal Zip Code 2,139
    • entity Address State Or Province MA
    • entity Central Index Key 1,682,852
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 001-38753
    • entity Filer Category Large Accelerated Filer
    • entity Incorporation State Country Code DE
    • entity Interactive Data Current Yes
    • entity Name Moderna, Inc.
    • entity Registrant Name Moderna, Inc.
    • entity Shell Company false
    • entity Small Business false
    • entity Tax Identification Number 81-3467528
    • finance Lease Liability 984,000,000
    • finance Lease Liability Current 153,000,000
    • finance Lease Liability Current Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
    • finance Lease Liability Noncurrent 831,000,000
    • finance Lease Liability Payments Due 1,637,000,000
    • finance Lease Liability Payments Due Next Twelve Months 128,000,000
    • finance Lease Liability Payments Due Year Four 23,000,000
    • finance Lease Liability Payments Due Year Three 107,000,000
    • finance Lease Liability Payments Due Year Two 128,000,000
    • finance Lease Liability Undiscounted Excess Amount 653,000,000
    • finance Lease Right Of Use Asset 1,033,000,000
    • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --305,000,000
    • income Tax Expense Benefit --384,000,000
    • increase Decrease In Accounts Payable --117,000,000
    • increase Decrease In Accounts Receivable --272,000,000
    • increase Decrease In Contract With Customer Liability --819,000,000
    • increase Decrease In Inventories --216,000,000
    • increase Decrease In Other Operating Liabilities --15,000,000
    • inventory Net 732,000,000
    • irs Number 813,467,528
    • lessee Operating Lease Liability Payments Due 159,000,000
    • lessee Operating Lease Liability Payments Due Next Twelve Months 23,000,000
    • lessee Operating Lease Liability Payments Due Year Four 19,000,000
    • lessee Operating Lease Liability Payments Due Year Three 18,000,000
    • lessee Operating Lease Liability Payments Due Year Two 20,000,000
    • lessee Operating Lease Liability Undiscounted Excess Amount 35,000,000
    • liabilities 5,262,000,000
    • liabilities And Stockholders Equity 24,125,000,000
    • liabilities Current 3,499,000,000
    • local Phone Number 714-6500
    • net Cash Provided By Used In Financing Activities --542,000,000
    • net Cash Provided By Used In Investing Activities 2,011,000,000
    • net Cash Provided By Used In Operating Activities --1,225,000,000
    • net Income Loss 79,000,000
    • operatingand Finance Lease Liability 1,108,000,000
    • operatingand Finance Lease Rightof Use Asset 1,150,000,000
    • operating Income Loss --366,000,000
    • operating Lease Liability 124,000,000
    • operating Lease Liability Current 28,000,000
    • operating Lease Liability Current Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
    • operating Lease Liability Noncurrent 96,000,000
    • operating Lease Right Of Use Asset 117,000,000
    • other Assets Current 64,000,000
    • other Assets Noncurrent 1,164,000,000
    • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 103,000,000
    • other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax --16,000,000
    • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 79,000,000
    • other Liabilities Current 212,000,000
    • other Liabilities Noncurrent 163,000,000
    • other Noncash Income Expense 4,000,000
    • other Nonoperating Income Expense --48,000,000
    • payments For Repurchase Of Common Stock 526,000,000
    • payments To Acquire Available For Sale Securities Debt 1,085,000,000
    • payments To Acquire Businesses Net Of Cash Acquired 85,000,000
    • payments To Acquire Property Plant And Equipment 113,000,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 1,360,000,000
    • proceeds From Sale Of Available For Sale Securities Debt 1,957,000,000
    • report Link https://www.sec.gov/Archives/edgar/data/1682852/000168285223000021/mrna-20230331_htm.xml
    • research And Development Expense 1,131,000,000
    • retained Earnings Accumulated Deficit 18,399,000,000
    • share Based Compensation 75,000,000
    • stockholders Equity 18,863,000,000
    • trading Symbol MRNA
    • update 1970-01-01
    • weighted Average Number Diluted Shares Outstanding Adjustment 19,000,000
    • weighted Average Number Of Diluted Shares Outstanding 405,000,000
    • weighted Average Number Of Shares Outstanding Basic 386,000,000
    • id REPORTED_FINANCIALS
    • key MRNA
    • subkey 10-Q
    • date 2023-05-04
    • updated 2023-05-05
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

MRNA stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001682852-23-000021
  • accounts Payable Current 389,000,000
  • accounts Receivable Net Current 1,113,000,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --267,000,000
  • allocated Share Based Compensation Expense 75,000,000
  • amendment Flag false
  • assets 24,125,000,000
  • assets Current 12,122,000,000
  • available For Sale Securities Debt Maturities Single Maturity Date 1970-05-30
  • cash And Cash Equivalents At Carrying Value 3,441,000,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 3,461,000,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 244,000,000
  • cik 1,682,852
  • city Area Code 617
  • common Stock Par Or Stated Value Per Share 0.0001
  • common Stock Shares Authorized 1,600,000,000
  • common Stock Shares Issued 384,000,000
  • common Stock Shares Outstanding 384,000,000
  • comprehensive Income Net Of Tax 182,000,000
  • contract With Customer Liability 1,892,000,000
  • contract With Customer Liability Current 1,219,000,000
  • cost Of Goods And Services Sold 792,000,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-04
  • depreciation Depletion And Amortization 78,000,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic 0.2
  • earnings Per Share Diluted 0.19
  • effective Income Tax Rate Continuing Operations 1.259
  • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized 789,000,000
  • employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 P3Y2M12D
  • entity Address Address Line 1 200 Technology Square
  • entity Address City Or Town Cambridge,
  • entity Address Postal Zip Code 2,139
  • entity Address State Or Province MA
  • entity Central Index Key 1,682,852
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-38753
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code DE
  • entity Interactive Data Current Yes
  • entity Name Moderna, Inc.
  • entity Registrant Name Moderna, Inc.
  • entity Shell Company false
  • entity Small Business false
  • entity Tax Identification Number 81-3467528
  • finance Lease Liability 984,000,000
  • finance Lease Liability Current 153,000,000
  • finance Lease Liability Current Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
  • finance Lease Liability Noncurrent 831,000,000
  • finance Lease Liability Payments Due 1,637,000,000
  • finance Lease Liability Payments Due Next Twelve Months 128,000,000
  • finance Lease Liability Payments Due Year Four 23,000,000
  • finance Lease Liability Payments Due Year Three 107,000,000
  • finance Lease Liability Payments Due Year Two 128,000,000
  • finance Lease Liability Undiscounted Excess Amount 653,000,000
  • finance Lease Right Of Use Asset 1,033,000,000
  • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --305,000,000
  • income Tax Expense Benefit --384,000,000
  • increase Decrease In Accounts Payable --117,000,000
  • increase Decrease In Accounts Receivable --272,000,000
  • increase Decrease In Contract With Customer Liability --819,000,000
  • increase Decrease In Inventories --216,000,000
  • increase Decrease In Other Operating Liabilities --15,000,000
  • inventory Net 732,000,000
  • irs Number 813,467,528
  • lessee Operating Lease Liability Payments Due 159,000,000
  • lessee Operating Lease Liability Payments Due Next Twelve Months 23,000,000
  • lessee Operating Lease Liability Payments Due Year Four 19,000,000
  • lessee Operating Lease Liability Payments Due Year Three 18,000,000
  • lessee Operating Lease Liability Payments Due Year Two 20,000,000
  • lessee Operating Lease Liability Undiscounted Excess Amount 35,000,000
  • liabilities 5,262,000,000
  • liabilities And Stockholders Equity 24,125,000,000
  • liabilities Current 3,499,000,000
  • local Phone Number 714-6500
  • net Cash Provided By Used In Financing Activities --542,000,000
  • net Cash Provided By Used In Investing Activities 2,011,000,000
  • net Cash Provided By Used In Operating Activities --1,225,000,000
  • net Income Loss 79,000,000
  • operatingand Finance Lease Liability 1,108,000,000
  • operatingand Finance Lease Rightof Use Asset 1,150,000,000
  • operating Income Loss --366,000,000
  • operating Lease Liability 124,000,000
  • operating Lease Liability Current 28,000,000
  • operating Lease Liability Current Statement Of Financial Position Extensible List http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
  • operating Lease Liability Noncurrent 96,000,000
  • operating Lease Right Of Use Asset 117,000,000
  • other Assets Current 64,000,000
  • other Assets Noncurrent 1,164,000,000
  • other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent 103,000,000
  • other Comprehensive Income Loss Reclassification Adjustment From AOCI For Sale Of Securities Net Of Tax --16,000,000
  • other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 79,000,000
  • other Liabilities Current 212,000,000
  • other Liabilities Noncurrent 163,000,000
  • other Noncash Income Expense 4,000,000
  • other Nonoperating Income Expense --48,000,000
  • payments For Repurchase Of Common Stock 526,000,000
  • payments To Acquire Available For Sale Securities Debt 1,085,000,000
  • payments To Acquire Businesses Net Of Cash Acquired 85,000,000
  • payments To Acquire Property Plant And Equipment 113,000,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • proceeds From Maturities Prepayments And Calls Of Available For Sale Securities 1,360,000,000
  • proceeds From Sale Of Available For Sale Securities Debt 1,957,000,000
  • report Link https://www.sec.gov/Archives/edgar/data/1682852/000168285223000021/mrna-20230331_htm.xml
  • research And Development Expense 1,131,000,000
  • retained Earnings Accumulated Deficit 18,399,000,000
  • share Based Compensation 75,000,000
  • stockholders Equity 18,863,000,000
  • trading Symbol MRNA
  • update 1970-01-01
  • weighted Average Number Diluted Shares Outstanding Adjustment 19,000,000
  • weighted Average Number Of Diluted Shares Outstanding 405,000,000
  • weighted Average Number Of Shares Outstanding Basic 386,000,000
  • id REPORTED_FINANCIALS
  • key MRNA
  • subkey 10-Q
  • date 2023-05-04
  • updated 2023-05-05